Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Internatl. marketing code for drugs

Executive Summary

FDA Com. Young and Associate Com. for Health Affairs Stuart Nightingale, MD, are preparing to argue against the need for a code as U.S. govt. representatives at the Conference of Experts on the Rational Use of Drugs, Nov. 23-25 in Nairobi, Kenya. Sponsored by the World Health Organization, the conference is a preliminary session to the May 1986 World Health Assembly. The marketing code concept is strongly opposed by the Pharmaceutical Mfrs. Assn. and the Proprietary Assn. ("The Pink Sheet" Oct. 14, T&G-3).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS009182

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel